心血管デバイス市場：デバイスタイプ、適応症、エンドユーザー別-2024～2030年の世界予測

心血管デバイス市場規模は、2023年に536億9,000万米ドルと推定され、2024年には575億5,000万米ドルに達し、CAGR 7.38%で2030年には884億米ドルに達すると予測されています。

心血管デバイスは、心臓や循環器系全般に関する疾患の診断、治療、管理に使用される専門的な機器やツールです。ペースメーカー、ステント、心臓弁、監視装置、手術器具など、幅広い製品が含まれます。人口の高齢化、座りがちなライフスタイル、高血圧、糖尿病、肥満などの危険因子の蔓延によって、世界的に心血管疾患の発生率が上昇していることが、普及の原動力となっています。技術の革新と研究開発の進歩が相まって、これらの機器の有効性と安全性が大幅に向上し、需要をさらに押し上げています。しかし、市場は厳しい規制状況、高度な心血管デバイスに関連する高コスト、高度な機器を操作する熟練した専門家の必要性などの課題に直面しています。一方、新興市場は、医療費の増加、継続的な心臓の健康モニタリングのためのウェアラブル技術の統合、心血管疾患に対する意識の高まり、低侵襲手術に対する需要の高まりから、大きな成長機会となります。さらに、費用対効果の高い結果を提供する革新的な製品につながる継続的な調査により、この分野の拡大に新たな道が開ける可能性があります。

デバイスの種類高血圧の診断と管理に不可欠な血圧モニターの採用が急増

血圧モニターは動脈内の血液の圧力を測定し、高血圧の診断と管理に不可欠です。心臓CT・MRIスキャナーは、心臓の構造と機能の詳細な画像を提供する高度な画像診断ツールであり、心臓の病気や状態の発見に役立ちます。心電図装置（ECG装置）は、心臓の電気的活動を一定期間記録し、心臓のリズムやその他の心血管系の問題を診断します。ホルター・モニターは心電図に類似したもので、この携帯型装置は心臓のリズムと電気的活動を24時間以上追跡し、標準的な心電図検査では現れないような不整脈の検出に役立ちます。遠隔心臓モニタリングシステムは、ワイヤレス技術を使って離れた場所から患者の心臓の活動をモニタリングすることができ、慢性的な心臓病の患者に特に有用です。負荷試験システムは、通常トレッドミルや固定式自転車などの物理的負荷がかかった状態での心臓の機能を調べる。安静時には気づかない心臓の病気を発見することができます。人工心臓は、機能不全に陥った心臓の代わりに移植される装置で、通常は心臓移植が可能になるまで一時的に使用されます。心筋焼灼カテーテルは、心筋焼灼術として知られる手技で使用され、異常な心リズムを誘発する心臓の組織に傷をつけたり、破壊したりすることで異常な心リズムを治療します。冠動脈ガイドワイヤーは細くて柔軟なワイヤーで、心臓の閉塞した動脈を開く処置の際に、ステントやバルーンなどの器具の配置を誘導するのに有用です。心臓モニターはホルターモニターに似たもので、心臓の活動を記録し、長時間使用することができます。手術後や長期の心臓病の診断によく使用されます。心臓弁は機械的なものと生物学的なものがあり、病気になった心臓弁の代わりとして使用され、心臓弁膜症の管理に重要です。植込み型除細動器（ICD）は心臓のリズムを監視し、必要に応じて電気ショックを与えて正常なリズムに戻します。心臓突然死の危険性がある患者に使用されます。ペースメーカーは、異常な心臓のリズムをコントロールするために胸に埋め込み、電気パルスを使って心臓が正常に拍動するように促します。ステントは、狭い動脈や閉塞した動脈に挿入して開通を維持し、心臓への血流を改善する小さな管です。補助人工心臓（VAD）は、心臓の機能が弱った人の心臓の機能と血流をサポートする機械的なポンプです。

エンドユーザー：外来手術センターにおける心血管デバイスの利用拡大

外来手術センターは、入院を必要としない手術や特定の医療処置を提供するヘルスケア施設です。その費用対効果と効率性から、ASCは心臓関連の小手術の心血管デバイスとしてますます利用されるようになっています。これらのセンターは、診断検査や小手術を含む外来心臓処置のための装置を備えています。ASCの重要な利点は、高品質でタイムリーな患者ケアを提供し、入院の必要性を減らすことができることです。病院には、必要不可欠な診断機器から高度な手術機器まで、あらゆるレベルの心臓治療に対応する幅広い機器が備えられています。病院は、急性心疾患の管理、重要な手術の実施、診断、治療、リハビリテーションを含む包括的ケアの提供の中心的存在です。病院の広範なインフラと学際的なチームは、複雑な心臓血管の症例に対応するために不可欠であり、心臓血管機器市場において重要な役割を担っています。専門クリニックはヘルスケアの特定の側面に重点を置いており、心臓病学と循環器系の健康だけに特化したクリニックもあります。これらのクリニックでは、主に診断目的、継続的な患者のモニタリング、軽度の治療処置に心血管デバイスを活用しています。専門クリニックは、ターゲットを絞った個別ケアを提供することで知られており、心臓病患者の特定のニーズに合わせたサービスを提供することが多いです。慢性心血管病の管理、予防戦略、患者教育が中心で、より高度な治療が必要な場合は病院と連携することも多いです。

地域別の洞察

南北アメリカでは、高いヘルスケア支出、洗練されたヘルスケアシステム、大手機器メーカーの存在感が市場成長の原動力となっています。この地域の規制枠組みは厳しく、食品医薬品局（FDA）が安全性と有効性を確保するための機器承認を監督しています。アジア太平洋（APAC）地域では、ヘルスケア施設の改善、可処分所得の増加、心血管疾患の負担増により、心血管デバイス市場が急速に拡大しています。この地域は、規制の成長段階が異なる国々が存在する多様な規制状況に特徴付けられ、企業は慎重に対応しなければならないです。とはいえ、中国やインドといった急成長中の経済圏は、医療をより身近なものにするために政府が医療インフラや保険制度への投資を増やしているため、医療機器メーカーにとって大きなビジネスチャンスとなっています。EMEA（欧州・中東・アフリカ）地域では、高齢化、医療水準の向上、心血管疾患管理を目的とした政府の積極的な取り組みにより、心血管デバイスに対する需要が高まっています。この地域で事業を展開する企業は、欧州諸国の先進的なヘルスケアシステムと中東・アフリカの新興市場の可能性から利益を得ており、市場参入と拡大を支援する規制の枠組みが発展しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは心血管デバイス市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、心血管デバイス市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.心血管デバイス市場の市場規模および予測は？

2.心血管デバイス市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.心血管デバイス市場の技術動向と規制枠組みは？

4.心血管デバイス市場における主要ベンダーの市場シェアは？

5.心血管デバイス市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 心血管疾患の負担増加
    • 低侵襲手術への関心の高まり
    • 新興国におけるヘルスケア施設の改善とヘルスケアサービスの範囲の拡大
  • 抑制要因
    • 厳格な規制政策と製品リコール
  • 機会
    • 心臓の健康を継続的に監視するためのウェアラブル技術の統合
    • 心臓血管機器の生体適合性と材料科学に関する継続的な調査
  • 課題
    • 払い戻しポリシーの数が限られている
• 市場セグメンテーション分析
  • デバイスタイプ：高血圧の診断と管理に不可欠な血圧計の採用が急増
  • エンドユーザー：外来手術センター全体での心血管デバイスの利用の進化
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 心血管デバイス市場デバイスタイプ別

• 診断および監視デバイス
• 治療および外科用機器

第7章 心血管デバイス市場適応症別

• 心不整脈
• 冠動脈疾患
• 心不全
• 末梢動脈疾患

第8章 心血管デバイス市場：エンドユーザー別

• 外来手術センター
• 病院
• 専門クリニック

第9章 南北アメリカの心血管デバイス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の心血管デバイス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの心血管デバイス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • ジョンソン・エンド・ジョンソンがショックウェーブ・メディカルを131億米ドルで買収、心臓血管ケアの提供を強化
  • メドトロニックとカーディアック・デザイン・ラボがインドで革新的な外部ループ・レコーダー技術を発表
  • InfoBionicのMoMe ARCが心臓モニタリングの革命としてFDAの承認を取得
• 戦略分析と提言

第13章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. CARDIOVASCULAR DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. CARDIOVASCULAR DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. CARDIOVASCULAR DEVICES MARKET DYNAMICS
• FIGURE 7. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. CARDIOVASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 22. CARDIOVASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CARDIOVASCULAR DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC CT & MRI SCANNERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC CT & MRI SCANNERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ELECTROCARDIOGRAM DEVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ELECTROCARDIOGRAM DEVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOLTER MONITORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOLTER MONITORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REMOTE CARDIAC MONITORING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REMOTE CARDIAC MONITORING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY STRESS TEST SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY STRESS TEST SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ARTIFICIAL HEARTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ARTIFICIAL HEARTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC ABLATION CATHETERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC ABLATION CATHETERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CORONARY GUIDEWIRES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CORONARY GUIDEWIRES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART MONITORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART MONITORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART VALVES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PACEMAKERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY STENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 49. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC ARRHYTHMIA, BY REGION, 2018-2023 (USD MILLION)
• TABLE 50. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC ARRHYTHMIA, BY REGION, 2024-2030 (USD MILLION)
• TABLE 51. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 52. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 53. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 54. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART FAILURE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 55. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 56. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 57. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 58. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 59. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 60. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 61. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 62. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 63. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 64. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 65. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
• TABLE 66. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
• TABLE 67. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
• TABLE 68. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
• TABLE 69. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
• TABLE 70. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
• TABLE 71. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 72. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 73. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 74. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 75. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 76. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 77. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
• TABLE 78. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
• TABLE 79. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
• TABLE 80. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
• TABLE 81. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
• TABLE 82. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
• TABLE 83. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 84. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 85. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 86. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 87. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
• TABLE 88. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
• TABLE 89. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
• TABLE 90. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
• TABLE 91. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
• TABLE 92. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
• TABLE 93. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 94. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 95. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 96. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 97. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
• TABLE 98. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
• TABLE 99. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
• TABLE 100. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
• TABLE 101. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
• TABLE 102. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
• TABLE 103. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 104. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 105. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 106. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 107. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
• TABLE 108. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
• TABLE 109. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
• TABLE 110. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
• TABLE 111. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
• TABLE 112. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
• TABLE 113. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 114. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 115. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 116. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 117. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
• TABLE 118. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
• TABLE 119. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
• TABLE 120. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
• TABLE 121. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
• TABLE 122. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
• TABLE 123. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 124. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 125. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 126. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 127. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 128. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 129. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
• TABLE 130. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
• TABLE 131. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
• TABLE 132. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
• TABLE 133. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
• TABLE 134. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
• TABLE 135. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 136. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 137. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 138. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 139. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 140. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 141. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
• TABLE 142. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
• TABLE 143. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
• TABLE 144. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
• TABLE 145. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
• TABLE 146. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
• TABLE 147. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 148. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 149. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 150. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 151. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
• TABLE 152. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
• TABLE 153. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
• TABLE 154. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
• TABLE 155. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
• TABLE 156. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
• TABLE 157. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 158. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 159. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 160. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 161. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
• TABLE 162. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
• TABLE 163. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
• TABLE 164. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
• TABLE 165. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
• TABLE 166. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
• TABLE 167. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 168. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 169. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 170. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 171. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
• TABLE 172. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
• TABLE 173. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
• TABLE 174. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
• TABLE 175. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
• TABLE 176. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
• TABLE 177. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 178. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 179. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 180. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 181. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
• TABLE 182. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
• TABLE 183. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
• TABLE 184. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
• TABLE 185. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
• TABLE 186. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
• TABLE 187. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 188. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 189. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 190. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 191. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
• TABLE 192. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
• TABLE 193. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
• TABLE 194. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
• TABLE 195. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
• TABLE 196. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
• TABLE 197. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 198. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 199. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 200. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 201. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
• TABLE 202. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
• TABLE 203. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
• TABLE 204. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
• TABLE 205. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
• TABLE 206. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
• TABLE 207. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 208. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 209. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 210. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 211. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
• TABLE 212. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
• TABLE 213. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
• TABLE 214. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
• TABLE 215. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
• TABLE 216. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
• TABLE 217. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 218. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 219. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 220. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 221. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
• TABLE 222. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
• TABLE 223. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
• TABLE 224. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
• TABLE 225. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
• TABLE 226. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
• TABLE 227. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 228. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 229. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 230. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 231. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
• TABLE 232. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
• TABLE 233. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
• TABLE 234. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
• TABLE 235. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
• TABLE 236. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
• TABLE 237. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 238. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 239. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 240. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 241. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
• TABLE 242. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
• TABLE 243. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
• TABLE 244. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
• TABLE 245. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
• TABLE 246. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
• TABLE 247. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 248. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 249. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 250. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 251. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
• TABLE 252. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
• TABLE 253. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
• TABLE 254. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
• TABLE 255. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
• TABLE 256. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
• TABLE 257. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 258. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 259. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 260. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 261. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
• TABLE 262. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
• TABLE 263. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
• TABLE 264. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
• TABLE 265. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
• TABLE 266. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
• TABLE 267. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 268. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 269. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 270. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 271. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 272. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 273. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
• TABLE 274. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
• TABLE 275. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
• TABLE 276. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
• TABLE 277. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
• TABLE 278. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
• TABLE 279. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 280. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 281. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 282. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 283. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
• TABLE 284. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
• TABLE 285. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
• TABLE 286. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
• TABLE 287. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
• TABLE 288. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
• TABLE 289. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 290. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 291. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 292. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 293. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
• TABLE 294. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
• TABLE 295. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
• TABLE 296. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
• TABLE 297. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
• TABLE 298. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
• TABLE 299. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 300. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 301. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 302. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 303. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
• TABLE 304. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
• TABLE 305. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
• TABLE 306. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
• TABLE 307. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
• TABLE 308. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
• TABLE 309. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 310. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 311. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 312. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 313. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
• TABLE 314. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
• TABLE 315. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGN

[183 Pages Report] The Cardiovascular Devices Market size was estimated at USD 53.69 billion in 2023 and expected to reach USD 57.55 billion in 2024, at a CAGR 7.38% to reach USD 88.40 billion by 2030.

Cardiovascular devices are specialized equipment and tools deployed in diagnosing, treating, and managing diseases related to the heart and the overall cardiovascular system. This range encompasses a broad spectrum of products, including pacemakers, stents, heart valves, monitoring devices, and surgical instruments. The rising incidences of cardiovascular diseases globally, driven by an aging population, sedentary lifestyles, and the prevalence of risk factors including hypertension, diabetes, and obesity, drive the adoption. Innovations in technology, coupled with advancements in research and development, have significantly improved the efficacy and safety of these devices, further propelling their demand. However, the market faces challenges, including stringent regulatory landscapes, high costs associated with advanced cardiovascular devices, and the need for skilled professionals to operate sophisticated equipment. On the other hand, emerging markets represent a significant opportunity for growth, given the increasing healthcare expenditure, wearable technology integration for continuous heart health monitoring, growing awareness about cardiovascular diseases, and the rising demand for minimally invasive procedures. Moreover, continuous research leading to innovative products that offer cost-effective outcomes can open new avenues for expansion in this sector.

Device Type: Burgeoning adoption of blood pressure monitors essential for diagnosing and managing hypertension

Blood pressure monitors measure the pressure of blood in the arteries, which is essential for diagnosing and managing hypertension. Cardiac CT & MRI scanners are advanced imaging tools that provide detailed pictures of the heart's structure and function, helping detect heart diseases and conditions. Electrocardiogram devices (ECG devices) record the heart's electrical activity over a period for diagnosing heart rhythms and other cardiovascular problems. Holter monitors are similar to ECGs; these portable devices track the heart's rhythm and electrical activity for 24 hours or more, helping detect irregularities that might not appear during a standard ECG exam. Remote cardiac monitoring systems allow for monitoring a patient's heart activity from a distance using wireless technology, which is especially useful for patients with chronic heart conditions. Stress test systems examine the heart's performance under physical stress, usually on a treadmill or stationary bike. They can detect heart diseases that are not noticeable at rest. Artificial hearts are devices implanted to replace the failing heart, usually used temporarily until a heart transplant can be performed. Cardiac ablation catheters are used in a procedure known as cardiac ablation, and they treat abnormal heart rhythms by scarring or destroying tissue in the heart that triggers abnormal heart rhythm. Coronary guidewires are thin, flexible wires that are useful in guiding the placement of devices such as stents or balloons during procedures to open up blocked arteries in the heart. Heart monitors are similar to Holter monitors; these devices keep track of the heart's activity and can be used for extended periods. They are often used after surgery or to diagnose long-term heart conditions. Heart valves can be mechanical or biological used to replace diseased heart valves and are critical in managing heart valve disorders. Implantable cardioverter defibrillators (ICDs) monitor heart rhythms and deliver electric shocks to restore a normal rhythm if necessary. They're used in patients at risk of sudden cardiac death. Pacemakers are implanted in the chest to control abnormal heart rhythms and use electrical pulses to prompt the heart to beat normally. Stents are tiny tubes inserted into narrow or blocked arteries to keep them open, improving blood flow to the heart. Ventricular assist devices (VADs) are mechanical pumps that support heart function and blood flow in individuals with weakened hearts.

End-User: Evolving utilization of cardiovascular devices across the ambulatory surgical centers

Ambulatory surgical centers are healthcare facilities that deliver surgery and specific medical procedures that do not require hospital admission. Due to their cost-effectiveness and efficiency, ASCs are increasingly utilized as cardiovascular devices for minor heart-related procedures. These centers have devices for outpatient cardiac procedures, including diagnostic tests and minor surgical interventions. The critical advantage of ASCs is their ability to offer high-quality, timely patient care, reducing the need for hospital stays. Hospitals are equipped with an expansive range of devices, from essential diagnostic tools to advanced surgical equipment, catering to all levels of cardiac care. Hospitals are central to managing acute cardiac conditions, performing significant surgeries, and providing comprehensive care, including diagnosis, treatment, and rehabilitation. The extensive infrastructure and multidisciplinary teams in hospitals are essential for handling complex cardiovascular cases, making them critical players in the cardiovascular device market. Specialty clinics focus on specific aspects of healthcare, with certain clinics dedicated entirely to cardiology and cardiovascular health. These clinics utilize cardiovascular devices primarily for diagnostic purposes, ongoing patient monitoring, and minor treatment procedures. Specialty clinics are known for providing targeted and personalized care, often offering services tailored to the specific needs of patients with heart diseases. They significantly manage chronic cardiovascular conditions, prevention strategies, and patient education, frequently collaborating with hospitals for more advanced care needs.

Regional Insights

In the Americas, the market growth is driven by high healthcare expenditure, sophisticated healthcare systems, and a strong presence of major device manufacturers. The regulatory framework in this region is stringent, with the food and drug administration (FDA) overseeing device approval to ensure safety and efficacy. In the Asia-Pacific (APAC) region, the market for cardiovascular devices is expanding rapidly due to improving healthcare facilities, increasing disposable incomes, and a growing burden of cardiovascular diseases. The region is marked by a diverse regulatory landscape with countries at different stages of regulatory growth, which companies must navigate carefully. Nonetheless, fast-growing economies such as China and India provide significant opportunities for device manufacturers, as governments increasingly invest in health infrastructure and insurance schemes to make healthcare more accessible. The EMEA region showcases a demand for cardiovascular devices driven by an aging population, rising healthcare standards, and favorable government initiatives aimed at cardiovascular disease management. Companies operating in this region benefit from the advanced healthcare systems in European countries and emerging market potential in the Middle East and Africa, guided by the evolving regulatory frameworks to support market entry and expansion.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cardiovascular Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cardiovascular Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cardiovascular Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACS Diagnostics, Alivecor, Inc., Asahi Kasei Corporation, B. Braun SE, Baxter International Inc., Bexen Medical, Biotronik SE & Co KG, Boston Scientific Corporation, BPL Medical Technologies Private Limited, GE Healthcare, HeartFlow Holding, Inc., Johnson & Johnson Services, Inc., Koninklijke Philips N.V.,, Lepu Medical Technology(Beijing)Co., Ltd., LivaNova PLC, Medtronic PLC, Microport Scientific Corporation, Nihon Kohden Corporation, Qardio, Inc., Schiller AG, Terumo Medical Corporation, Tricog Health, Vesalius Cardiovascular Inc., and Zoll Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiovascular Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Device Type
  • Diagnostic & Monitoring Devices
    • Blood Pressure Monitors
    • Cardiac CT & MRI Scanners
    • Electrocardiogram Devices
    • Holter Monitors
    • Remote Cardiac Monitoring
    • Stress Test Systems

• Therapeutic & Surgical Devices
  • Artificial Hearts
  • Cardiac Ablation Catheters
  • Coronary Guidewires
  • Heart Monitors
  • Heart Valves
  • Implantable Cardioverter Defibrillators
  • Pacemakers
  • Stents
  • Ventricular Assist Devices
• Indication
  • Cardiac Arrhythmia
  • Coronary Artery Disease
  • Heart Failure
  • Peripheral Arterial Disease

• End-User
  • Ambulatory Surgical Centers
  • Hospitals
  • Specialty Clinics

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cardiovascular Devices Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cardiovascular Devices Market?

3. What are the technology trends and regulatory frameworks in the Cardiovascular Devices Market?

4. What is the market share of the leading vendors in the Cardiovascular Devices Market?

5. Which modes and strategic moves are suitable for entering the Cardiovascular Devices Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing burden of cardiovascular diseases
    • 5.1.1.2. Rising preference for minimally invasive procedures
    • 5.1.1.3. Improved healthcare facilities and the expanding reach of healthcare services in emerging economies
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent regulatory policies and product recalls
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of wearable technology for continuous monitoring of heart health
    • 5.1.3.2. Ongoing research in the biocompatibility and material science of cardiovascular device
  • 5.1.4. Challenges
    • 5.1.4.1. Limited number of reimbursement policies
• 5.2. Market Segmentation Analysis
  • 5.2.1. Device Type: Burgeoning adoption of blood pressure monitors essential for diagnosing and managing hypertension
  • 5.2.2. End-User: Evolving utilization of cardiovascular devices across the ambulatory surgical centers
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Cardiovascular Devices Market, by Device Type

• 6.1. Introduction
• 6.2. Diagnostic & Monitoring Devices
• 6.3. Therapeutic & Surgical Devices

7. Cardiovascular Devices Market, by Indication

• 7.1. Introduction
• 7.2. Cardiac Arrhythmia
• 7.3. Coronary Artery Disease
• 7.4. Heart Failure
• 7.5. Peripheral Arterial Disease

8. Cardiovascular Devices Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Hospitals
• 8.4. Specialty Clinics

9. Americas Cardiovascular Devices Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Cardiovascular Devices Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Cardiovascular Devices Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Johnson & Johnson Acquires Shockwave Medical for USD 13.1 Billion, Bolstering Its Cardiovascular Care Offerings
  • 12.3.2. Medtronic and Cardiac Design Labs Unveil Revolutionary External Loop Recorder Technology in India
  • 12.3.3. InfoBionic's MoMe ARC Receives FDA Approval for Revolutionizing Cardiac Monitoring
• 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

• 13.1. Key Company Profiles
• 13.2. Key Product Portfolio